1.1: sulfur / 7 h / 110 °C
2.1: sodium hydroxide; water / ethanol / 17 h / 80 °C
2.2: pH 2
3.1: N-ethyl-N,N-diisopropylamine; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; benzotriazol-1-ol / N,N-dimethyl-formamide / 12 h / 20 °C
4.1: sodium tetrahydroborate; acetic acid / 1,4-dioxane / 3.5 h / 10 - 105 °C
5.1: hydrogenchloride / water / 30 °C
5.2: 1 h / 0 - 20 °C
5.3: 1 h
6.1: sodium hydroxide / ethanol; water / 0.5 h / 60 °C / Inert atmosphere
6.2: 12 h / 60 °C / Inert atmosphere
View Scheme
参考文献
INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCE P.L.A.CHINA
Patent: US2012/122914 A1, 2012 ;
1.1: sodium tetrahydroborate; acetic acid / 1,4-dioxane / 3.5 h / 10 - 105 °C
2.1: hydrogenchloride / water / 30 °C
2.2: 1 h / 0 - 20 °C
2.3: 1 h
3.1: sodium hydroxide / ethanol; water / 0.5 h / 60 °C / Inert atmosphere
3.2: 12 h / 60 °C / Inert atmosphere
View Scheme
参考文献
INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCE P.L.A.CHINA
Patent: US2012/122914 A1, 2012 ;